Smith MR - Search Results

1

Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies.

Bellmunt J, Kheoh T, Yu MK, Smith MR, Small EJ, Mulders PF, Fizazi K, Rathkopf DE, Saad F, Scher HI, Taplin ME, Davis ID, Schrijvers D, Protheroe A, Molina A, De Porre P, Griffin TW, de Bono JS, Ryan CJ, Oudard S. Bellmunt J, et al. Among authors: smith mr. Eur Urol. 2016 May;69(5):924-32. doi: 10.1016/j.eururo.2015.10.021. Epub 2015 Oct 24. Eur Urol. 2016. PMID: 26508309 Free PMC article. Clinical Trial.

2

Osteoporosis during androgen deprivation therapy for prostate cancer.

Smith MR. Smith MR. Urology. 2002 Sep;60(3 Suppl 1):79-85; discussion 86. Urology. 2002. PMID: 12231056 Review.

3

Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer.

Smith MR, Fallon MA, Goode MJ. Smith MR, et al. Urology. 2003 Jan;61(1):127-31. doi: 10.1016/s0090-4295(02)02006-x. Urology. 2003. PMID: 12559282

4

Prostate cancer: metastatic.

Michaelson MD, Talcott JA, Smith MR. Michaelson MD, et al. Among authors: smith mr. Clin Evid. 2002 Dec;(8):881-90. Clin Evid. 2002. Update in: Clin Evid. 2003 Dec;(10):1012-22. PMID: 12603918 Updated. Review. No abstract available.

5

Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.

Smith MR, Eastham J, Gleason DM, Shasha D, Tchekmedyian S, Zinner N. Smith MR, et al. J Urol. 2003 Jun;169(6):2008-12. doi: 10.1097/01.ju.0000063820.94994.95. J Urol. 2003. PMID: 12771706 Clinical Trial.

6

Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up.

Oh WK, Manola J, Bittmann L, Brufsky A, Kaplan ID, Smith MR, Kaufman DS, Kantoff PW. Oh WK, et al. Among authors: smith mr. Urology. 2003 Jul;62(1):99-104. doi: 10.1016/s0090-4295(03)00145-6. Urology. 2003. PMID: 12837431 Clinical Trial.

7

Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.

Small EJ, Smith MR, Seaman JJ, Petrone S, Kowalski MO. Small EJ, et al. Among authors: smith mr. J Clin Oncol. 2003 Dec 1;21(23):4277-84. doi: 10.1200/JCO.2003.05.147. Epub 2003 Oct 27. J Clin Oncol. 2003. PMID: 14581438 Clinical Trial.

8

Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer.

Smith MR. Smith MR. Urology. 2004 Apr;63(4):742-5. doi: 10.1016/j.urology.2003.10.063. Urology. 2004. PMID: 15072892 Clinical Trial.

9

Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.

Oh WK, Kantoff PW, Weinberg V, Jones G, Rini BI, Derynck MK, Bok R, Smith MR, Bubley GJ, Rosen RT, DiPaola RS, Small EJ. Oh WK, et al. Among authors: smith mr. J Clin Oncol. 2004 Sep 15;22(18):3705-12. doi: 10.1200/JCO.2004.10.195. Epub 2004 Aug 2. J Clin Oncol. 2004. PMID: 15289492 Clinical Trial.

10

Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy.

Smith MR, Manola J, Kaufman DS, George D, Oh WK, Mueller E, Slovin S, Spiegelman B, Small E, Kantoff PW. Smith MR, et al. Cancer. 2004 Oct 1;101(7):1569-74. doi: 10.1002/cncr.20493. Cancer. 2004. PMID: 15468186 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,177 results

Search Page

Filters